Pan-cancer analysis of the prognosis and immunological role of AKAP12: A potential biomarker for resistance to anti-VEGF inhibitors.

Liang, Qiuju; Peng, Jinwu; Xu, Zhijie; Li, Zhilan; Jiang, Feng; Ouyang, Lingzi; Wu, Shangjun; Fu, Chencheng; Liu, Ying; Liu, Yuanhong; Yan, Yuanliang

Liang, Qiuju; Peng, Jinwu; Xu, Zhijie; Li, Zhilan; Jiang, Feng; Ouyang, Lingzi; Wu, Shangjun; Fu, Chencheng; Liu, Ying; Liu, Yuanhong; Yan, Yuanliang.

Afiliação

Liang Q; Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Peng J; National Clinical Research Center for Geriatric Disorders, Institute for Rational and Safe Medication Practices, Xiangya Hospital, Central South University, Changsha, China.
Xu Z; Department of Pathology, Xiangya Hospital, Central South University, Changsha, China.
Li Z; Department of Pathology, Xiangya Changde Hospital, Changde, China.
Jiang F; Department of Pathology, Xiangya Hospital, Central South University, Changsha, China.
Ouyang L; Department of Pathology, Xiangya Changde Hospital, Changde, China.
Wu S; Department of Pathology, Xiangya Changde Hospital, Changde, China.
Fu C; Department of Pathology, Xiangya Changde Hospital, Changde, China.
Liu Y; Department of Pathology, Xiangya Changde Hospital, Changde, China.
Liu Y; Department of Pathology, Xiangya Changde Hospital, Changde, China.
Yan Y; Department of Pathology, Xiangya Changde Hospital, Changde, China.

Front Genet ; 13: 943006, 2022.

Article em En | MEDLINE | ID: mdl-36110213

Palavras-chave

AKAP12; immune infiltration; pan-cancer analysis; prognosis; resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Genet Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google